New MS Treatment Shows Promise in Trial

An experimental antibody therapy called ublituximab has been found to reduce symptom flare-ups in multiple sclerosis (MS) patients by preventing relapses and areas of inflammatory damage in the brain. If approved by the FDA, it would be the latest in a group of MS therapies called anti-CD20 monoclonal antibodies. Recent developments in this field show…

Read More

Health Bulletin 09/December/2023

NMC relief for overseas medical students in the Philippines allows students enrolled in BS courses before new regulations to continue their medical education. In Bihar, four doctors and a clerk at a medical institute have been accused of demanding sexual favors from paramedic students in exchange for better grades. Elsewhere, a doctor in Kerala has…

Read More

FDA Approves Not One, But Two Sickle Cell Disease Gene Therapies

The FDA approved gene therapies from Vertex Pharmaceuticals and Bluebird Bio for sickle cell disease. Both treatments, Casgevy and Lyfgenia, use gene therapy to potentially cure the inherited blood disorder and target those aged 12 and older. Sickle Cell Disease is a rare, debilitating, and life-threatening blood disorder with significant unmet need. Healthy red blood…

Read More

Don’t wait for the draft – Volunteer!

The author reflects on the power of volunteering and the impact it has on individuals and communities. They share their experiences of witnessing volunteering in the US and in Ireland, highlighting the diversity of volunteer work and the positive effects it has on society. They also speak about their own involvement as a volunteer for…

Read More

What is Urinary Incontinence? | Medical News Bulletin

Urinary incontinence is a common problem affecting approximately 30% of the world’s population. This includes stress incontinence, urge incontinence, overflow incontinence, total incontinence, and nocturnal enuresis. Causes for this include pelvic floor damage, neuromuscular damage, blockage of the urethra, and inability to control bladder movement. In addition, issues with your sleeping patterns and sex life…

Read More

Mosie Baby receives first 510(k) clearance for at-home artificial insemination kit

The at-home fertility care company Mosie Baby received FDA 510(k) clearance for its over-the-counter intravaginal insemination kit, allowing individuals to perform at-home insemination with fresh or frozen donor semen. The kit retails for $129.99 and includes two syringes and collection cups. Mosie’s CEO, Maureen Brown, expressed pride in helping over 100,000 families. The company plans…

Read More

Managing myopia progression results in long-term savings

Serge Resnikoff, MD, PhD, chair of the International Myopia Institute, discussed the cost of early management of myopia progression at the FLORetina meeting. He dispelled misconceptions about the high cost, stating that a recent study showed the lifetime cost of myopia management is equivalent to traditional myopia correction with single vision glasses. While special glasses,…

Read More
error: Content is protected !!